Filter
8493
Filtered Results: 8493
Text search:
guidance
Featured
Recommendations
944
New Publications
1970
Language
Document type
No document type
4240
Guidelines
1589
Studies & Reports
1156
Manuals
529
Strategic & Response Plan
314
Fact sheets
250
Training Material
175
Situation Updates
80
Resource Platforms
56
Infographics
40
Online Courses
27
Brochures
25
Videos
9
App
3
Countries / Regions
Global
354
India
317
Kenya
210
Sierra Leone
169
Western and Central Europe
147
Nigeria
146
South Africa
145
Ethiopia
144
Liberia
143
Uganda
135
Myanmar / Burma
128
Nepal
127
Latin America and the Carribbean
123
Syria
113
Africa
112
Zambia
109
Russia
102
Malawi
100
Bangladesh
92
Tanzania
91
Rwanda
84
Ukraine
84
Middle East and North Africa
80
Brazil
78
Ghana
77
South Sudan
65
West and Central Africa
65
Congo, Democratic Republic of
64
Mozambique
59
East and Southern Africa
59
Philippines
57
Eastern Europe
56
South–East Asia Region
55
Namibia
52
Guinea
51
Indonesia
50
Yemen
50
Eastern Europe and Central Asia
50
Senegal
41
Germany
41
Lesotho
41
Zimbabwe
39
Asia
37
Cambodia
36
Haiti
35
Colombia
31
Angola
31
Burkina Faso
30
Lebanon
29
Botswana
29
Mali
27
Venezuela
27
Pakistan
26
Sudan
23
Guinea-Bissau
21
Eswatini/ Swaziland
21
Western Pacific Region
21
Afghanistan
20
Vietnam
20
Côte d’Ivoire / Ivory Coast
19
USA
19
China
16
Cameroon
15
Somalia
15
Laos
15
Spain
15
Jordan
14
Thailand
14
Argentina
14
Iraq
13
Ecuador
12
Central African Republic
11
Madagascar
11
United Kingdom
11
Niger
10
Chad
9
Benin
9
Peru
9
Moldova
9
Georgia
9
Saudi Arabia
8
Turkey
8
Bolivia
8
Sri Lanka
8
Chile
8
Paraguay
8
Kyrgyzstan
8
Papua New Guinea
7
Albania
7
Kazakhstan
7
North America
7
Portugal
7
North Macedonia
6
Palestine
6
Tajikistan
6
Ireland
5
Bhutan
5
Italy
5
Armenia
5
Timor Leste/ East Timor
5
Iran
5
Gambia
4
Malaysia
4
El Salvador
4
Greece
4
Mexico
4
Southern Africa
4
Congo-Brazzaville
4
Estonia
4
Uzbekistan
4
Jamaica
4
Morocco
3
Togo
3
Singapore
3
Serbia
3
Burundi
3
Libya
3
Romania
3
Turkmenistan
3
Japan
3
France
3
Bosnia and Herzegovina
3
Egypt
2
Mauritania
2
Switzerland
2
Hungary
2
Poland
2
North Korea
2
Qatar
2
Bulgaria
2
Australia
2
Tunisia
2
South Korea
2
Belarus
2
Israel
2
Dominican Republic
1
Croatia
1
Honduras
1
Guatemala
1
Nicaragua
1
Fiji
1
Djibouti
1
Canada
1
Slovakia
1
Gabon
1
Uruguay
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Norway
1
Azerbaijan
1
French Guyana
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2804
Clinical Guidelines
656
Women & Child Health
508
Key Resources
464
Public Health
459
Capacity Building
200
Pharmacy & Technologies
103
Annual Report MEDBOX
2
Toolboxes
COVID-19
1413
HIV
616
Mental Health
573
TB
398
Disability
334
Ebola
282
Rapid Response
276
Planetary Health
266
Caregiver
252
AMR
241
Conflict
218
Refugee
161
NTDs
157
Pharmacy
141
NCDs
140
Global Health Education
117
Natural Hazards
116
Zika
98
Specific Hazards
74
Cholera
55
Polio
54
Health Financing Toolbox
54
Social Ethics
34
Typhoon
3
South Sudan
1
Health Financing
1
These guidelines have been compiled for education ministries or other educational leaders (including development partners, non-governmental or private organizations working with schools or directly with caregivers) who want to adapt and adopt resources to support the marginalized caregivers of child...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD D...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO N...
Yaws, a neglected tropical disease (NTD) of the skin caused by the bacterium Treponema pallidum subspecies pertenue, is targeted in the latest WHO NTD Roadmap for eradication by 2030. In January, 2022, WHO published a manual that outlines the key activities that Ministries of Health in endemic count...
The new WHO recommendations for rabies immunization supersede the 2010 WHO position
on pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) for rabies. These updated
recommendations are based on new evidence and directed by public health needs that are cost-,
dose- and time-sparing...
During the 17 years since Surgical approaches to the urogenital manifestations of lymphatic filariasis was first published, there has been heightened awareness of the physical, economic and emotional burden of the genitourinary manifestations of filariasis. With the impetus to provide better ... for care of those suffering from LF, this update was both warranted and timely.
At the outset, the Committee noted that barriers continue to exist in care of patients affected by LF-associated morbidity. These barriers include lack of information for patients as well as for many healthcare providers, including general surgeons and others within health systems
This update offers a new consensus of the Committee regarding the staging of hydroceles caused by LF, also known as “filariceles”. It recommends integrating LF surgery with other efforts to strengthen surgical care by assessing health facilities for their surgical readiness using the WHO surgical assessment tool or “SAT”. It also recommends integratinghernia surgery with hydrocele surgery and integrating standards for prevention of surgical site infection (SSI).
The update revises recommendations for standard procedures and processes, offers an algorithm for diagnosis (including the use of ultrasound) and discusses postoperative care. It recommends collecting data using the staging and grading system described by Capuano and Capuano along with other metrics for public health management of LF.
A multifaceted approach has therefore been recommended to coordinate public health outreach with national surgical planning and local health systems to include supporting partners such as nongovernmental organizations. Surgical camps with mobile teams, as well as training of personnel at DCP3 “first level” or WHO Level II hospitals (depending on region and resources), have important roles for reducing LF morbidity.
At its 48th session of Codex Committee on Food Hygiene (CCFH), the Committee noted the importance of water quality and safety in food production and processing. CCFH requested the Food and Agriculture Organization of the United Nations
(FAO) and the World Health Organization (WHO) to provide ... for those scenarios where the use of “clean water” (i.e. water that does not compromise the safety of the food in the context of its use) was indicated in Codex texts and on
where it is appropriate to use “clean water”. In particular, guidance was sought for the use of irrigation water and “clean” seawater and on the safe reuse of processing water.
The objective of Critical Considerations and Actions for Achieving Universal Access to Sexual and Reproductive Health in the Context of Universal Health Coverage through a Primary Health Care Approach is to provide guidance to WHO Member States for ...
This Urban Flood Risk Handbook: Assessing Risk and Identifying Interventions is a roadmap for conducting an urban flood risk assessment in any city in the world. It includes practical guidance for a flood risk assessment project, covering the key ha...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The ... includes updated risk rates for hospital admission in patients with non-severe COVID-19.
The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients.
This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines:
**High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%.
**Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%.
Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk.
Review of COVID-19 treatments for people with non-severe COVID-19
WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022.
If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead.
WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission.
For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol.
WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials.
The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials.
Nutrition data and information systems (ND&IS) are critical to guide the prioritisation, collection, analysis and
dissemination of nutrition data in countries. However, there is limited guidance for countries regarding how to invest
in their ND&IS...
Food inspection is crucial for ensuring food safety, using risk-based approaches to target high-risk products and businesses. This guidance aids national authorities in designing and implementing risk-based systems, offering step-by-step instruction...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providin...
The document is part of the briefing package for Ethiopia's Water, Sanitation, and Hygiene (WASH) Cluster, which consists of resources that provide greater clarity and guidance to the cluster partners and other humanitarian actors.
The document i...
Evidence-based psychological interventions are an important part of health, social, protection and education services and can help increase access to effective mental health treatments and progression towards universal health coverage.
This manual provides managers and others responsible for plan...
The document "Diabetes in Pregnancy" by NICE (National Institute for Health and Care Excellence) outlines quality standards for managing diabetes in women during pregnancy, with a focus on five key areas. First, it emphasizes the importance of preconception planning for women of childbearing age wit...
This document updates the 1999 World Health Organization (WHO) classification of diabetes. It prioritizes clinical care and guides health professionals in choosing appropriate treatments at the time of diabetes diagnosis, and provides practical guidance...
This publication provides an overview of the rehabilitation landscape in Armenia as of 1 November 2022. It summarizes notable accomplishments, identifies requirements and highlights opportunities for improvement within the rehabilitation sector in Armenia. The assessment was carried out under the ... of the Ministry of Health of Armenia, along with its Health Care Policy Department. Technical assistance was provided by the WHO Regional Office for Europe and the WHO Country Office in Armenia.
The WHO document "Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance" provides a framework for integrating noncommunicable diseases (NC...
An integrated approach is particularly important for low-resource settings for efficient use of limited resources. The course contents will include risk factors, clinical course, guidance and protocols for diagnosis, management and referral as neede...
